Showing posts with label
Viking Therapeutics
.
Show all posts
Showing posts with label
Viking Therapeutics
.
Show all posts
Friday, June 27, 2025
We added to our position in Viking Therapeutics last week as the summer of Bio Tech M&A moves forward!
›
Lipid and metabolic disorders are a broad group of conditions that affect how the body processes fats (lipids) and energy. Here's a ...
Tuesday, February 18, 2025
Will 2025 bring a buyout offer for Viking Therapeutics and their cutting edge drug pipeline? Stay tuned!
›
Viking Therapeutics (VKTX) – Investment & Business Report (February 2025) Company Overview Viking Therapeutics, Inc. (NASDAQ: VKTX) is...
Friday, January 31, 2025
How Viking Therapeutics is challenging Eli Lilly and Novo Nordisk in the weight loss (anti-obesity) therapeutics market!
›
Viking Therapeutics (VKTX) Investment Report January 2025 1. Executive Summary Viking Therapeutics (NASDAQ: VKTX) has emerged as a key con...
Friday, January 17, 2025
"NASH" is a serious healthcare problem and it is one important reason why Viking Therapeutics might become a takeover target!
›
Viking Therapeutics (NASDAQ: VKTX) Viking Therapeutics is a clinical-stage biopharmaceutical company focused primarily on the development ...
›
Home
View web version
